Singapore markets closed
Straits Times Index
3,292.93 -3.96 (-0.12%) Nikkei
38,236.07 -37.98 (-0.10%) Hang Seng
18,475.92 +268.79 (+1.48%) FTSE 100
8,213.49 +41.34 (+0.51%) Bitcoin USD
62,732.98 +3,049.61 (+5.11%) CMC Crypto 200
1,359.39 +82.41 (+6.45%)
Cipla Limited (CIPLA.BO)
BSE - BSE Real-time price. Currency in INR
Add to watchlist
At close: 03:29PM IST
| Previous close | 1,419.55 |
| Open | 1,423.00 |
| Bid | 1,425.00 x 0 |
| Ask | 1,425.10 x 0 |
| Day's range | 1,416.40 - 1,434.20 |
| 52-week range | 897.70 - 1,519.00 |
| Volume | |
| Avg. volume | 31,867 |
| Market cap | 1.15T |
| Beta (5Y monthly) | 0.37 |
| PE ratio (TTM) | 31.05 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 8.50 (0.60%) |
| Ex-dividend date | 21 Jul 2023 |
| 1y target est | N/A |
- PR Newswire
Cipla announces joint venture in the United States with Kemwell Biopharma and Manipal Education & Medical Group for global development and commercialisation of innovative Cell therapy products
Cipla (EU) Limited, UK a wholly owned subsidiary of Cipla Limited (BSE:500087; NSE: Cipla EQ], hereinafter referred to as Cipla has announced a strategic collaboration with Kemwell Biopharma Private Limited (through its subsidiary Kemwell Biopharma UK Limited) and Manipal Education & Medical Group (through its subsidiary MNI Ventures, Mauritius) to incorporate a joint venture in the United States. The primary goal of this joint venture is to develop and commercialise novel Cell therapy products
© 2024 Yahoo. All rights reserved.